Steven W. Sanders

Person

Salt Lake City, UT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for unoccluded transdermal oxybutynin therapy
- Patent number 10,272,061
- Issue date Apr 30, 2019
- Allergan Sales, LLC
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Unoccluded topical oxybutynin gel composition and methods for trans...
- Patent number 8,241,662
- Issue date Aug 14, 2012
- Watson Laboratories, Inc.
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for transdermal oxybutynin therapy
- Patent number 7,179,483
- Issue date Feb 20, 2007
- Watson Pharmaceuticals, Inc.
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for minimizing adverse drug experiences as...
- Patent number 7,087,241
- Issue date Aug 8, 2006
- Watson Laboratories, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for minimizing adverse drug experiences as...
- Patent number 7,081,249
- Issue date Jul 25, 2006
- Watson Laboratories, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for minimizing adverse drug experiences as...
- Patent number 7,081,250
- Issue date Jul 25, 2006
- Watson Laboratories, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for minimizing adverse drug experiences as...
- Patent number 7,081,251
- Issue date Jul 25, 2006
- Watson Laboratories, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for minimizing adverse drug experiences as...
- Patent number 7,081,252
- Issue date Jul 25, 2006
- Watson Laboratories, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for transdermal oxybutynin therapy
- Patent number 7,029,694
- Issue date Apr 18, 2006
- Watson Laboratories, Inc.
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for minimizing adverse drug experiences as...
- Patent number 6,743,441
- Issue date Jun 1, 2004
- Watson Pharmaceuticals, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TRANSDERMAL OXYBUTYNIN THERAPY
- Publication number 20170095438
- Publication date Apr 6, 2017
- ALLERGAN SALES, LLC
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Transdermal Oxybutynin Therapy
- Publication number 20090018190
- Publication date Jan 15, 2009
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for transdermal oxybutynin therapy
- Publication number 20070148195
- Publication date Jun 28, 2007
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for minimizing adverse drug experiences as...
- Publication number 20060078613
- Publication date Apr 13, 2006
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for transdermal oxybutynin therapy
- Publication number 20050226898
- Publication date Oct 13, 2005
- Watson Pharmaceuticals, Inc.
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for minimizing adverse drug experiences as...
- Publication number 20050048106
- Publication date Mar 3, 2005
- Watson Pharmaceuticals, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for minimizing adverse drug experiences as...
- Publication number 20050048107
- Publication date Mar 3, 2005
- Watson Pharmaceuticals, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for minimizing adverse drug experiences as...
- Publication number 20040259954
- Publication date Dec 23, 2004
- Watson Pharmaceuticals, Inc.
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for minimizing adverse drug experiences as...
- Publication number 20040120996
- Publication date Jun 24, 2004
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for transdermal oxybutynin therapy
- Publication number 20030147926
- Publication date Aug 7, 2003
- Watson Pharmaceuticals, Inc.
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for transdermal oxybutynin therapy
- Publication number 20030124177
- Publication date Jul 3, 2003
- Watson Pharmaceuticals, Inc.
- Charles D. Ebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for minimizing adverse drug experiences as...
- Publication number 20020147236
- Publication date Oct 10, 2002
- Steven W. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Steven W. Sanders

Person

Patents Grantslast 30 patents

Compositions and methods for unoccluded transdermal oxybutynin therapy

Unoccluded topical oxybutynin gel composition and methods for trans...

Compositions and methods for transdermal oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for transdermal oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences as...

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TRANSDERMAL OXYBUTYNIN THERAPY

Compositions and Methods for Transdermal Oxybutynin Therapy

Compositions and methods for transdermal oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for transdermal oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for minimizing adverse drug experiences as...

Compositions and methods for transdermal oxybutynin therapy

Compositions and methods for transdermal oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences as...